Letter by Chin et al regarding article, "Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial analysis".

Chin, Paul K L; Wright, Daniel F B; Florkowski, Christopher M

Chin, Paul K L; Wright, Daniel F B; Florkowski, Christopher M.

Affiliation

Chin PK; Department of Clinical Pharmacology, Christchurch Hospital, Christchurch, New Zealand.
Wright DF; School of Pharmacy, University of Otago, Dunedin, New Zealand.
Florkowski CM; Canterbury Health Laboratories, Christchurch, New Zealand.

Circulation ; 130(22): e194, 2014 Nov 25.

Article in En | MEDLINE | ID: mdl-25421050

Subject(s)

Atrial Fibrillation/drug therapy; Atrial Fibrillation/physiopathology; Benzimidazoles/adverse effects; Benzimidazoles/therapeutic use; Kidney/physiology; Warfarin/adverse effects; Warfarin/therapeutic use; beta-Alanine/analogs & derivatives; Female; Humans; Male

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Warfarin / Benzimidazoles / Beta-Alanine / Kidney Type of study: Clinical_trials Limits: Female / Humans / Male Language: En Journal: Circulation Year: 2014 Document type: Article

Fulltext

XML

PubMed Links

Search on Google